64 related articles for article (PubMed ID: 215448)
1. [Antiphosphodiesterase activity of papaveroline/sulfonic acid. In vitro spectrophotometric determination].
Castellani G; Zagaria F
Farmaco Prat; 1978; 33(4):187-93. PubMed ID: 215448
[No Abstract] [Full Text] [Related]
2. Behavioural effects of selective PDE4 inhibitors in relation to inhibition of catalytic activity and competition for [3H]rolipram binding.
Kapui Z; Bence J; Boronkay E; Mikus E; Urbán Szabó K; Baranyi A; Arányi P
Neurobiology (Bp); 1999; 7(1):71-3. PubMed ID: 10746252
[No Abstract] [Full Text] [Related]
3. Influence of papaverine derivatives on phosphodiesterase activity, cyclic 3',5'-AMP levels and relaxing effect on rabbit ileum.
Berndt SF; Schulz HU; Stock K
Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep; 294(3):271-5. PubMed ID: 187961
[TBL] [Abstract][Full Text] [Related]
4. A structure-activity relationship study on papaverine analogs.
Gupta SP; Garg C; Gupta JK
Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):265-8. PubMed ID: 2847262
[TBL] [Abstract][Full Text] [Related]
5. [Effects of papaveroline monosulfate on systemic and regional circulation in the dog].
Cacchio M; Data PG; Rolfo A
Boll Soc Ital Biol Sper; 1977 Jun; 53(12):1010-6. PubMed ID: 597419
[No Abstract] [Full Text] [Related]
6. Relationships between structure and vascular activity in a series of benzylisoquinolines.
Chulia S; Ivorra MD; Martinez S; Elorriaga M; Valiente M; Noguera MA; Lugnier C; Advenier C; D'Ocon P
Br J Pharmacol; 1997 Oct; 122(3):409-16. PubMed ID: 9351495
[TBL] [Abstract][Full Text] [Related]
7. Effect of papaverine analogues on 3', 5'-adenosine monophosphate phosphodiesterase activity in rat brain.
Stancheva S; Uzunov P; Stoytchev T
Acta Physiol Pharmacol Bulg; 1980; 6(1):41-7. PubMed ID: 6250318
[TBL] [Abstract][Full Text] [Related]
8. [Cerebral ischemic vasculopathy: clinical and thermographic study in patients treated with papaveroline].
Nico F; Guercini F; Biagi A; Fanfoni S
Clin Ter; 1981 Jul; 98(2):195-200. PubMed ID: 7261566
[No Abstract] [Full Text] [Related]
9. [Papaveroline in mental disorders caused by a deficit of non-focalized cerebral circulation].
Pala A; Alleva PM
Clin Ter; 1981 Jan; 96(1):39-44. PubMed ID: 7237948
[No Abstract] [Full Text] [Related]
10. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.
Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y
Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP phosphodiesterase inhibitors depress production of plasminogen activator by Chinese hamster ovary cells.
Mott DM; Fabisch PH; Sorof S
Biochem Biophys Res Commun; 1976 Jun; 70(4):1150-6. PubMed ID: 182161
[No Abstract] [Full Text] [Related]
12. Demonstration of functional compartments of cyclic AMP in rat platelets by the use of phosphodiesterase inhibitors.
Ashida S; Sakuma K
Adv Second Messenger Phosphoprotein Res; 1992; 25():229-39. PubMed ID: 1313259
[No Abstract] [Full Text] [Related]
13. Cyclic AMP phosphodiesterase inhibition by coumarins and furanocoumarins.
Sardari S; Nishibe S; Horita K; Nikaido T; Daneshtalab M
Pharmazie; 1999 Jul; 54(7):554-6. PubMed ID: 10445247
[No Abstract] [Full Text] [Related]
14. Studies on the effect of nicotinamide and ethylnicotinic acid on cyclic AMP phosphodiesterase from rat liver.
Hoshi Y
Bull Osaka Med Sch; 1975 Oct; 21(2):77-91. PubMed ID: 181108
[No Abstract] [Full Text] [Related]
15. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
Nemoz G; Prigent AF
Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
[No Abstract] [Full Text] [Related]
16. [3',5'-cAMP phosphodiesterase inhibitors in the combined treatment of patients with rheumatoid arthritis].
Bakaliuk OI; Shved MI; Hrebenyk MV
Lik Sprava; 1998 Aug; (6):34-7. PubMed ID: 9844866
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
Kass DA
Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
[No Abstract] [Full Text] [Related]
18. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
19. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
20. New substituted triaza-benzo[cd]azulen-9-ones as promising phosphodiesterase-4 inhibitors.
Devillers I; Pevet I; Jacobelli H; Durand C; Fasquelle V; Puaud J; Gaudillière B; Idrissi M; Moreau F; Wrigglesworth R
Bioorg Med Chem Lett; 2004 Jun; 14(12):3303-6. PubMed ID: 15149695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
